Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.285    -0.01 (-3.39%)
Bid:
0.27
Ask:
0.30
Spread: 0.03 (11.111%)
Market Cap: £16.52m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Trading & Placing Update

3 Aug 2012 07:00

RNS Number : 1990J
CAP-XX Limited
03 August 2012
Β 

ο»Ώ

CAP-XX Limited

(the "Company" or "CAP-XX")

Β 

Trading & Placing Update

Β 

CAP-XX Limited, a world leader in the design and manufacture of revolutionary thin-form supercapacitors, announces that revenues for the year to 30 June 2012Β are expected to be AUD $3.5m. Volume and average selling prices are up approximately 15% and 1% respectively compared with the previous year. The loss before tax for the year is expected to be broadly in line with the prior year.

The Company continues to make good progress in direct sales of its supercapacitor products, which considerably extend the performance of conventional battery power systems and, in many new applications, completely eliminates the need for batteries. During the period under review, our licensee, Murata, announced a new "DMG" series of products targeting applications such as Solid State Drives and Automated/Smart Meters for which longer operational life at higher temperatures are required. Royalty payments from Murata have built more slowly than forecast, but their continued investment in product line extensions and increased manufacturing capacity targeted to mobile phone and camera market opportunities supports the Boards' expectations of sales growth over the coming years.

Good progress continues to be made in the development of large cell supercapacitors for automotive applications. Product specifications and requirements have been discussed with the major automotive OEMs and their Tier 1 suppliers, prototype samples provided to several for testing, and the design of a small scale production line completed.

Shipments recently commenced for an exciting new portable medical device to be launched by one of the world's leading diabetes management companies. Additionally new battery-free applications powered by ambient energy harvesters or quick charging systems continue to emerge and are predicted to grow substantially in the coming years.

Although general trading conditions remain flat, the Board continues to view the future with confidence, as the Company's technology is embraced by a widening variety of customers and markets.Β 

Placing Update

As part of the recent placing of 10,945,333 new ordinary shares announced on March 12, a Chinese automotive component company agreed to subscribe for 1,700,000 of these new ordinary shares in the company, subject to Chinese Government approval.

The Company previously announced that the process of finalising this investment had been delayed.Β Although the Company continues to pursue this subscription and discussions are ongoing to complete the investment, the Board considers that there is no certainty that the subscription will be completed.

As at June 30, 2012, the Company has AUD $3.8m of cash reserves.

Β 

For further information, please contact

Β 

CAP-XX Limited

Anthony Kongats, Chief Executive Officer

Β 

+61 (0) 2 9428 0139

Seymour Pierce Ltd

Freddy Crossley/Catherine Leftley (Nominated Adviser)

David Banks/Paul Jewell (Corporate Broking)

Β 

+44 (0) 20 7107 8000

Β 

Kreab Gavin Anderson & Company (Financial PR)

Robert Speed, Deborah Walter, Anthony Hughes

+44 (0) 20 7074 1800

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCUGUCURUPPGCP
Date   Source Headline
2nd Jul 20197:00 amRNSUS court action settlement and licence agreement
25th Jun 201910:45 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20198:59 amRNSHolding(s) in Company
6th Jun 20199:03 amRNSTrading Update
30th May 20198:27 amRNSHolding(s) in Company
17th Apr 20193:09 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSTrading Update
6th Mar 20197:00 amRNSInterim Results
1st Mar 20197:36 amRNSDirector Disclosure Update
22nd Jan 20198:32 amRNSHolding(s) in Company
20th Dec 20188:43 amRNSIssue of Shares and Director/PDMR Shareholdings
20th Nov 20188:29 amRNSResult of AGM and Chairman's AGM statement
14th Nov 20187:00 amRNSHolding(s) in Company
5th Nov 20187:00 amRNSSubscription to raise £1.75 million
23rd Oct 20187:00 amRNSExercise of share options & PDMR shareholding
22nd Oct 201810:09 amRNSNotice of AGM
17th Oct 20187:00 amRNSAudited results for the year ended 30 June 2018
8th Oct 20182:05 pmRNSSecond Price Monitoring Extn
8th Oct 20182:00 pmRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSNew licence agreement with TDK
5th Oct 20188:00 amRNSNotice of Results
25th Sep 201810:22 amRNSSpire Health Tags launched in Apple stores
18th Jul 20188:30 amRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSExercise of share options
22nd Jun 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
21st Jun 20187:00 amRNSExercise of share options & PDMR shareholding
20th Jun 20187:00 amRNSTrading update
1st May 20187:00 amRNSExercise of employee share options
11th Apr 20187:00 amRNSDeveloping first 3V thin prismatic supercapacitors
6th Mar 20182:25 pmRNSInterim Results (Replacement)
6th Mar 20187:00 amRNSInterim Results
15th Feb 20188:46 amRNSNotice of results
16th Jan 20187:00 amRNSHolding(s) in Company
18th Dec 201711:42 amRNSGrant of Share Options
12th Dec 201710:35 amRNSIssue of Shares and Director/PDMR Shareholdings
23rd Nov 20179:40 amRNSResult of AGM and Chairman's AGM statement
20th Nov 20177:00 amRNSSpire launches Thinline enabled wearable
30th Oct 20177:00 amRNSNotice of AGM
9th Oct 20177:00 amRNSAudited results for the year ended 30 June 2017
22nd Sep 20178:59 amRNSHolding(s) in Company
22nd Sep 20177:00 amRNSNotice of Results
23rd Aug 20178:37 amRNSHolding(s) in Company
15th Aug 20177:00 amRNSFirst high-volume order for Thinline
29th Jun 20178:22 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20177:00 amRNSTrading update for year ending 30 June 2017
25th May 20178:51 amRNSExtension of option term and Director/PDMR dealing
19th Apr 20178:47 amRNSHolding(s) in Company
20th Mar 20177:00 amRNSInterim Results
9th Mar 20177:00 amRNSCAP-XX launches new cylindrical supercapacitors
1st Feb 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.